Cardiac impact of inhaled therapy in the largest randomised placebo-controlled trial in COPD history: have we reached the SUMMIT?

SUMMIT supports the efficiency and cardiovascular safety of LABA and ICS in COPD patients at cardiovascular risk http://ow.ly/p6Is300ffoc

Detalles Bibliográficos
Autores principales: Andreas, Stefan, Janson, Christer, van den Berge, Maarten, Lahousse, Lies
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2016
Materias:
Clinical Signpost
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5005175/
https://www.ncbi.nlm.nih.gov/pubmed/27730192
http://dx.doi.org/10.1183/23120541.00055-2016
_version_ 1782450876265267200
author Andreas, Stefan
Janson, Christer
van den Berge, Maarten
Lahousse, Lies
author_facet Andreas, Stefan
Janson, Christer
van den Berge, Maarten
Lahousse, Lies
author_sort Andreas, Stefan
collection PubMed
description SUMMIT supports the efficiency and cardiovascular safety of LABA and ICS in COPD patients at cardiovascular risk http://ow.ly/p6Is300ffoc
format Online
Article
Text
id pubmed-5005175
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-50051752016-10-11 Cardiac impact of inhaled therapy in the largest randomised placebo-controlled trial in COPD history: have we reached the SUMMIT? Andreas, Stefan Janson, Christer van den Berge, Maarten Lahousse, Lies ERJ Open Res Clinical Signpost SUMMIT supports the efficiency and cardiovascular safety of LABA and ICS in COPD patients at cardiovascular risk http://ow.ly/p6Is300ffoc European Respiratory Society 2016-05-26 /pmc/articles/PMC5005175/ /pubmed/27730192 http://dx.doi.org/10.1183/23120541.00055-2016 Text en Copyright ©ERS 2016 http://creativecommons.org/licenses/by-nc/4.0/ This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
spellingShingle Clinical Signpost
Andreas, Stefan
Janson, Christer
van den Berge, Maarten
Lahousse, Lies
Cardiac impact of inhaled therapy in the largest randomised placebo-controlled trial in COPD history: have we reached the SUMMIT?
title Cardiac impact of inhaled therapy in the largest randomised placebo-controlled trial in COPD history: have we reached the SUMMIT?
title_full Cardiac impact of inhaled therapy in the largest randomised placebo-controlled trial in COPD history: have we reached the SUMMIT?
title_fullStr Cardiac impact of inhaled therapy in the largest randomised placebo-controlled trial in COPD history: have we reached the SUMMIT?
title_full_unstemmed Cardiac impact of inhaled therapy in the largest randomised placebo-controlled trial in COPD history: have we reached the SUMMIT?
title_short Cardiac impact of inhaled therapy in the largest randomised placebo-controlled trial in COPD history: have we reached the SUMMIT?
title_sort cardiac impact of inhaled therapy in the largest randomised placebo-controlled trial in copd history: have we reached the summit?
topic Clinical Signpost
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5005175/
https://www.ncbi.nlm.nih.gov/pubmed/27730192
http://dx.doi.org/10.1183/23120541.00055-2016
work_keys_str_mv AT andreasstefan cardiacimpactofinhaledtherapyinthelargestrandomisedplacebocontrolledtrialincopdhistoryhavewereachedthesummit
AT jansonchrister cardiacimpactofinhaledtherapyinthelargestrandomisedplacebocontrolledtrialincopdhistoryhavewereachedthesummit
AT vandenbergemaarten cardiacimpactofinhaledtherapyinthelargestrandomisedplacebocontrolledtrialincopdhistoryhavewereachedthesummit
AT lahousselies cardiacimpactofinhaledtherapyinthelargestrandomisedplacebocontrolledtrialincopdhistoryhavewereachedthesummit

Ejemplares similares